This is the
talk page for discussing improvements to the
Deferiprone article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Deferiprone.
|
just a note - today I removed the following: "Deferiprone is in clinical trials in the United States to treat Contrast-Induced Acute Kidney Injury and to slow progression of Chronic Kidney Disease; the trials are being conducted by the biotech company, Cormedix.(ref) http://www.cormedix.com/pipeline_CRMD001.php(/ref)." This is no longer true - see here http://www.dailyfinance.com/2013/03/27/cormedix-reports-year-end-2012-financial-results/ and here http://philadelphia.citybizlist.com/article/sec-filing-cormedix-terminates-agreement-shiva-biomedical. We should have had some MEDRS compliant source on this and we never did... Jytdog ( talk) 10:42, 1 October 2013 (UTC)
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A
Mainul Hoque, Hartmut M Hanauske-Abel, Paul Palumbo, Deepti Saxena, Darlene D'Alliessi Gandolfi, Myung Hee Park, Tsafi Pe'eryEmail author and Michael B Mathews author
Retrovirology 20096:90
DOI: 10.1186/1742-4690-6-90
https://retrovirology.biomedcentral.com/articles/10.1186/1742-4690-6-90
This is the
talk page for discussing improvements to the
Deferiprone article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Deferiprone.
|
just a note - today I removed the following: "Deferiprone is in clinical trials in the United States to treat Contrast-Induced Acute Kidney Injury and to slow progression of Chronic Kidney Disease; the trials are being conducted by the biotech company, Cormedix.(ref) http://www.cormedix.com/pipeline_CRMD001.php(/ref)." This is no longer true - see here http://www.dailyfinance.com/2013/03/27/cormedix-reports-year-end-2012-financial-results/ and here http://philadelphia.citybizlist.com/article/sec-filing-cormedix-terminates-agreement-shiva-biomedical. We should have had some MEDRS compliant source on this and we never did... Jytdog ( talk) 10:42, 1 October 2013 (UTC)
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A
Mainul Hoque, Hartmut M Hanauske-Abel, Paul Palumbo, Deepti Saxena, Darlene D'Alliessi Gandolfi, Myung Hee Park, Tsafi Pe'eryEmail author and Michael B Mathews author
Retrovirology 20096:90
DOI: 10.1186/1742-4690-6-90
https://retrovirology.biomedcentral.com/articles/10.1186/1742-4690-6-90